We are a biopharmaceutical company and wholly owned subsidiary of Alfasigma S.p.A. focused on the development and commercialization of novel therapeutics to treat rare and serious liver diseases, including primary biliary cholangitis (PBC) and severe alcohol-associated hepatitis (sAH). In a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with rare and serious liver disease. We are committed to improving patients’ lives and addressing the liver community’s most pressing needs. Our corporate headquarters is located in New Jersey. For more information about Intercept, please visit our website at: www.interceptpharma.com and follow us on X at: @InterceptPharma.
Looking for a particular Intercept Pharmaceuticals employee's phone or email?
Intercept Pharmaceuticals Questions
The Intercept Pharmaceuticals annual revenue was $101.3 million in 2026.
Rocco Venezia is the CFO of Intercept Pharmaceuticals.
336 people are employed at Intercept Pharmaceuticals.
Intercept Pharmaceuticals is based in Morristown, New Jersey.
The NAICS codes for Intercept Pharmaceuticals are [325414, 32, 325, 3254, 32541].
The SIC codes for Intercept Pharmaceuticals are [283, 28].
Top Intercept Pharmaceuticals Employees
-
Rocco Venezia
Chief Financial Officer at Intercept Pharmaceuticals
Morristown, NJ, US25+ -
25+
-
Deryk David
Senior Vice President at Intercept Pharmaceuticals
Lansdale, PA, US33 -
25 -
14
Related Companies
